Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.33 | Prev. Close $0.18 | Circuit Range N/A |
Day Range $0.26 - $0.38 | Year Range $0.11 - $2.66 | Volume 11,21,991 |
Average Traded $0.31 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
18-Mar-26 | $0.14 | $0.13 | -18.59% |
17-Mar-26 | $0.16 | $0.16 | -2.50% |
16-Mar-26 | $0.16 | $0.16 | -0.62% |
13-Mar-26 | $0.17 | $0.16 | -10.56% |
12-Mar-26 | $0.18 | $0.18 | -6.25% |
11-Mar-26 | $0.20 | $0.19 | -4.00% |
10-Mar-26 | $0.20 | $0.20 | -1.48% |